一名接受过彭博利珠单抗治疗的患者出现了迟发性自身免疫性胆管炎。

IF 0.5 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

BJR Case Reports Pub Date : 2024-11-01 DOI:10.1093/bjrcr/uaae040

Joshua Newington, Daniel Patterson, Pilar Sanchez

{"title":"一名接受过彭博利珠单抗治疗的患者出现了迟发性自身免疫性胆管炎。","authors":"Joshua Newington, Daniel Patterson, Pilar Sanchez","doi":"10.1093/bjrcr/uaae040","DOIUrl":null,"url":null,"abstract":"This case study describes a female patient in her late 70s who developed autoimmune cholangitis a year after finishing 35 cycles of pembrolizumab for the treatment of her non-small cell lung cancer. The diagnosis was initially missed and delayed; the patient's agoraphobia and the COVID-19 pandemic were noted as contributing factors.","PeriodicalId":45216,"journal":{"name":"BJR Case Reports","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543344/pdf/","citationCount":"0","resultStr":"{\"title\":\"Delayed onset autoimmune cholangitis in a patient treated with pembrolizumab.\",\"authors\":\"Joshua Newington, Daniel Patterson, Pilar Sanchez\",\"doi\":\"10.1093/bjrcr/uaae040\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This case study describes a female patient in her late 70s who developed autoimmune cholangitis a year after finishing 35 cycles of pembrolizumab for the treatment of her non-small cell lung cancer. The diagnosis was initially missed and delayed; the patient's agoraphobia and the COVID-19 pandemic were noted as contributing factors.\",\"PeriodicalId\":45216,\"journal\":{\"name\":\"BJR Case Reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543344/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BJR Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/bjrcr/uaae040\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJR Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/bjrcr/uaae040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

摘要

本病例研究描述了一名年过七旬的女性患者，在完成 35 个周期的 Pembrolizumab 治疗非小细胞肺癌一年后，患上了自身免疫性胆管炎。诊断最初被漏诊和延误；患者的恐旷症和 COVID-19 大流行被认为是诱因。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Delayed onset autoimmune cholangitis in a patient treated with pembrolizumab.

This case study describes a female patient in her late 70s who developed autoimmune cholangitis a year after finishing 35 cycles of pembrolizumab for the treatment of her non-small cell lung cancer. The diagnosis was initially missed and delayed; the patient's agoraphobia and the COVID-19 pandemic were noted as contributing factors.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

BJR Case Reports RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

自引率

0.00%

发文量

审稿时长

11 weeks